Beacon Medical Interchange

beaconmedic.com

 

Beacon Medical Interchange
Avatar

Is Progression-Free Survival without Overall Survival Benefit Enough?

By Beacon Medical Interchange FEATURING Jack West
By Beacon Medical Interchange FEATURING Jack West
271 views
October 29, 2018
Dr. Jack West discusses results and the significance of two important Japanese trials that test ...
read more ↘
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Lung
14:11

Key Findings From Study on Plasma-Based TMB as a Predictive Biomarke…

Beacon Medical Interchange

J. West, C. Aggarwal

18 views
08:34

Status of TMB as a Biomarker in NSCLC & Clinical Utility of Negative…

Beacon Medical Interchange

J. West, C. Aggarwal

29 views
09:09

Best Treatment First: Implications for Front - Loading Combinations …

Beacon Medical Interchange

J. West

210 views
09:07

How do Patients with Advanced NSCLC on Daily Steroids Do on Immune C…

Beacon Medical Interchange

J. West

655 views
07:05

FDA Approval of Dacomitinib for NSCLC - Is it the Gamechanger in the…

Beacon Medical Interchange

J. West

839 views
10:16

Is Progression-Free Survival without Overall Survival Benefit Enough?

Beacon Medical Interchange

J. West

271 views
07:12

Small Trial Shows Big Risks of First Line Pembro to EGFR Mutation-Po…

Beacon Medical Interchange

J. West

20 views
08:57

Nivo/Ipi Rx of Choice for Adv. NSCLC, PD-L1 Under 1%, High TMB? New …

Beacon Medical Interchange

J. West

60 views
09:33

Practice Changing Positive Keytruda Trial : Chemo +IO had significan…

Beacon Medical Interchange

J. West

254 views
11:06

KEYNOTE-042: Should Pembrolizumab Replace Chemo for Broader Populati…

Beacon Medical Interchange

J. West

1.9K views
10:18

My Top 5 ASCO 2018 Abstracts in Advanced NSCLC

Beacon Medical Interchange

J. West

14 views
07:13

My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung C…

Beacon Medical Interchange

J. West

34 views
15:37

Local Therapy for Advanced NSCLC: Revising Outdated Principles for S…

Beacon Medical Interchange

J. West

363 views
12:38

Is Chemo the Key for EGFR Mutation-Positive NSCLC? The Data Too Good…

Beacon Medical Interchange

J. West

10.0K views
08:10

IMpower131: Role for Carbo/Nab-Paclitaxel/Atezolizumab Combo for Adv…

Beacon Medical Interchange

J. West

20 views
13:08

Nivo/Ipi vs. Chemo in High TMB Advanced NSCLC: Key Results from Chec…

Beacon Medical Interchange

J. West

752 views
09:40

Are TMB and Nivolumab/Ipilimumab Ready for Clinical Use? Insights fr…

Beacon Medical Interchange

J. West

500 views
06:32

KEYNOTE-189: Clinical Implications in Patients with Less Than 1% Tum…

Beacon Medical Interchange

J. West

28 views
06:16

KEYNOTE-189: Clinical Implications in Patients with Low (1-49%) Tumo…

Beacon Medical Interchange

J. West

15 views
07:59

KEYNOTE-189: Clinical Implications for High Tumor PD-L1 Expression

Beacon Medical Interchange

J. West

14 views
05:03

Is Chemotherapy More Effective After Prior Immunotherapy?

Beacon Medical Interchange

J. West

20 views
11:35

New Insights on Acq. Resistance to Immune Checkpoint Inhibitors for …

Beacon Medical Interchange

J. West

14 views
13:06

Pembro + Chemo in Metastatic NSCLC - Key Summary of a Practice-Chang…

Beacon Medical Interchange

J. West

251 views
09:15

Chemo/Immunotherapy in Advanced Squamous NSCLC: What is the Impact o…

Beacon Medical Interchange

J. West

15 views
06:36

Afatinib in Patients With Uncommon EGFR Mutations In NSCLC

Beacon Medical Interchange

J. West

149 views
07:21

How Should We Monitor Patients After Potentially Curative Lung Cance…

Beacon Medical Interchange

J. West

10 views
07:01

Diminishing Returns after a Fixed Duration of Immunotherapy Treatmen…

Beacon Medical Interchange

J. West

14 views
02:40

Is There Still a Value in Testing for PD-L1 Expression in Advanced N…

Beacon Medical Interchange

J. West

13 views
03:35

Better Communication Leads to Better Outcomes for Cancer Patients

Beacon Medical Interchange

J. West

9 views
06:24

Are Two Immunotherapy Agents Better than One? Was the MYSTIC Trial a…

Beacon Medical Interchange

J. West

15 views
10:26

Is Immunotherapy Ineffective for Driver Mutation-positive Advanced N…

Beacon Medical Interchange

J. West

369 views
06:33

Is Durvalumab Curing Patients or Just Treating Metastatic Disease Ea…

Beacon Medical Interchange

J. West

196 views
07:44

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C…

Beacon Medical Interchange

J. West

20 views
08:13

Has the KEYNOTE-189 Trial Defined a Clear Standard of Care in Metast…

Beacon Medical Interchange

J. West

20 views
10:20

Is There a Better Lung Immunotherapy Biomarker than PD-L1?

Beacon Medical Interchange

J. West

186 views
11:29

Atezolizumab in First Line Metastatic NSCLC: Early Clinical Results …

Beacon Medical Interchange

J. West

26 views
08:55

Genomic Sequencing for All Solid Tumors: Where Will This Lead Us?

Beacon Medical Interchange

J. West

494 views
06:25

Dabrafenib/Trametinib for BRAF V600E Mutation-Positive Advanced NSCLC

Beacon Medical Interchange

J. West

21 views
11:47

Osimertinib as First-Line Treatment for EGFR Mutation-Positive Advan…

Beacon Medical Interchange

J. West

131 views
07:54

Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for…

Beacon Medical Interchange

J. West

142 views
05:53

Are PD-1/PD-L1 Immune Checkpoint Inhibitors Completely Interchangeab…

Beacon Medical Interchange

J. West

136 views
07:02

Will Immunotherapy Shift Treatment Balance for Borderline Resectable…

Beacon Medical Interchange

J. West

254 views
10:03

Research Question or Standard of Care: The Barriers to Broad Adoptio…

Beacon Medical Interchange

J. West

16 views
07:22

Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC

Beacon Medical Interchange

J. West

122 views
09:09

Tumor Mutational Burden in SCLC: A Valuable Immunotherapy Biomarker?

Beacon Medical Interchange

J. West

514 views
06:56

Chemo/Immunotherapy Data Increasingly Compelling with Additional Fol…

Beacon Medical Interchange

J. West

16 views
09:36

The FLAURA Trial: Practice-Changing Results for EGFR Mutation-Positi…

Beacon Medical Interchange

J. West

210 views
06:20

Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIF…

Beacon Medical Interchange

J. West

23 views
04:51

Early Returns on FLAURA Trial: Osimertinib as First Line Agent in EG…

Beacon Medical Interchange

J. West

14 views
04:19

Immunotherapy in Locally Advanced NSCLC - PACIFIC Study Shows Durval…

Beacon Medical Interchange

J. West

69 views
07:19

IMpower133: Is there Finally a New Standard of Care for Extensive St…

Beacon Medical Interchange

J. West

580 views
07:22

Updated Results on PACIFIC Trial: Revise Who Should Receive Consolid…

Beacon Medical Interchange

J. West

441 views
08:04

Long-Term Management on Immunotherapy for Advanced NSCLC: Insights f…

Beacon Medical Interchange

J. West

607 views
04:14

Pembrolizumab for PS2 Patients with Adv. NSCLC: Results of the PePS2…

Beacon Medical Interchange

J. West

19 views
06:39

The IMpower132 Trial: Does This Change the Advanced NSCLC Landscape?

Beacon Medical Interchange

J. West

21 views
09:43

The MYSTIC Trial has Failed on OS in Advanced NSCLC: What Does and D…

Beacon Medical Interchange

J. West

20 views
09:54

OS for Local Ablative Therapy for Oligometastatic NSCLC: Does it Fit…

Beacon Medical Interchange

J. West

13 views
09:59

Chemotherapy With or Without Immunotherapy in Stage IV Non-squamous …

Beacon Medical Interchange

J. West

171 views
08:59

Nivolumab vs. Chemo in Relapsed SCLC (review of Checkmate-331 trial)

Beacon Medical Interchange

J. West

190 views
13:29

Top 5 Most Influential Trial Findings in Lung Cancer Management in 2…

Beacon Medical Interchange

J. West

647 views
20:37

What is the Optimal Duration for Immunotherapy in Responding Patient…

Beacon Medical Interchange

J. West, D. Spigel

840 views
19:08

Changes in Lung Cancer Management, Addressing Stigma, and the Rise o…

Beacon Medical Interchange

J. Schiller, J. West

11 views
25:18

Overcoming Barriers in Cancer Care Delivery, Smoking Cessation, and …

Beacon Medical Interchange

G. Morgan, J. West

29 views
19:06

Weighing Clinical Significance of New Clinical Trial Results With Im…

Beacon Medical Interchange

J. West, C. Langer

543 views
25:42

Chest CT Screening and Pulmonary Workups in Lung Cancer Beyond Terti…

Beacon Medical Interchange

J. West, J. Gorden

271 views
20:09

Defining the Role of Interventional Pulmonology in Lung Cancer Manag…

Beacon Medical Interchange

J. West, J. Gorden

199 views
20:09

Why is Broader FDA Approval of First Pembrolizumab Monotherapy (KEYN…

Beacon Medical Interchange

J. West

1.2K views
26:53

Growing Momentum for Plasma-based Next Generation Sequencing in Adva…

Beacon Medical Interchange

J. West, C. Aggarwal

9 views
19:58

Current Practice & Challenges in Execution of Genomic Testing in Adv…

Beacon Medical Interchange

J. West, G. Riely

319 views
28:12

Should Local Ablation Therapy in Oligometastatic or Oligoprogressing…

Beacon Medical Interchange

J. West, G. Riely

25 views
18:01

Critical Review of Combining Radiation with Immunotherapy in Advance…

Beacon Medical Interchange

J. West

1.0K views
31:09

Open Questions in Radiation Oncology Care: From Proton Beam Radiatio…

Beacon Medical Interchange

J. West, D. Palma

91 views
12:47

Immunotherapy-Based Options for NSCLC: How to Decide Which Approach …

Beacon Medical Interchange

J. West, C. Aggarwal

18 views